Apoptosis is associated with increased cell surface tissue factor procoagulant activity

被引:0
|
作者
Greeno, EW
Bach, RR
Moldow, CF
机构
[1] VET AFFAIRS MED CTR,DEPT MED,MINNEAPOLIS,MN 55417
[2] UNIV MINNESOTA,DEPT MED,SECT HEMATOL,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue factor (TF), the physiologic initiator of coagulation, is present on the surface of cells but is not fully active unless the cell is lysed. This phenomenon, termed TF encryption, may be regulated by changes in membrane structure. Because apoptosis is associated with cell membrane alterations and conditions associated with apoptosis have also been associated with TF de-encryption, we hypothesized that apoptosis would result in enhanced TF procoagulant activity. Cultured human fibroblasts and endotoxin-stimulated endothelial cells were treated to induce apoptosis as evidenced by morphologic and DNA changes. Under the same conditions, changes in the level of TF activity were measured. Conditions that resulted in endothelial apoptosis were associated with de-encryption of TF activity. Similar results were obtained in fibroblasts except that only the morphologic changes, not the alterations in DNA size characteristic of apoptosis in other cells, were found. The data suggest an association between apoptosis and expression of cell surface tissue factor activity. Because of the recognized linkage of the coagulation system with wound healing and neoplasia, we speculate that this association may help to regulate the flux of cells in tissues being remodelled by apoptosis.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 50 条
  • [21] Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor
    Maroney, Susan A.
    Ellery, Paul E.
    Wood, Jeremy P.
    Ferrel, Josephine P.
    Bonesho, Catherine E.
    Mast, Alan E.
    BIOCHEMICAL JOURNAL, 2012, 443 : 259 - 266
  • [22] Activated EPCs produce tissue factor and have procoagulant activity
    Di Stefano, R.
    Celi, A.
    Santoni, T.
    Barsotti, M. C.
    Armani, C.
    Balbarini, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 688 - 688
  • [23] EXPRESSION OF TISSUE FACTOR PROCOAGULANT ACTIVITY - REGULATION BY CYTOSOLIC CALCIUM
    BACH, R
    RIFKIN, DB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) : 6995 - 6999
  • [24] Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity
    Bazzan, M
    Gruden, G
    Stella, S
    Vaccarino, A
    Tamponi, G
    Olivetti, C
    Giunti, S
    Cavallo-Perin, P
    DIABETOLOGIA, 1998, 41 (07) : 767 - 771
  • [25] Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity
    M. Bazzan
    G. Gruden
    S. Stella
    A. Vaccarino
    G. Tamponi
    C. Olivetti
    S. Giunti
    P. Cavallo-Perin
    Diabetologia, 1998, 41 : 767 - 771
  • [26] GLUCOCORTICOIDS INHIBIT THE GENERATION OF LEUKOCYTE PROCOAGULANT (TISSUE FACTOR) ACTIVITY
    MUHLFELDER, TW
    NIEMETZ, J
    KANG, S
    BLOOD, 1982, 60 (05) : 1169 - 1172
  • [27] TISSUE FACTOR ACTIVITY OF CELL-SURFACE COAT
    MAYNARD, JR
    HECKMAN, CA
    PITLICK, FA
    NEMERSON, Y
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 243 - 243
  • [28] Enhancement of tissue factor procoagulant activity by binding to hemoglobin.
    Siddiqui, FA
    Francis, JL
    BLOOD, 1999, 94 (10) : 92B - 92B
  • [29] Modification of tissue factor by peroxynitrite influences its procoagulant activity
    Adam, JM
    Ettelaie, C
    Naseem, KM
    James, NJ
    Bradley, NJ
    Bruckdorfer, KR
    FEBS LETTERS, 1998, 429 (03) : 347 - 350
  • [30] Tumor procoagulant activity is predominantly due to tissue factor expression
    Amirkhosravi, A
    Warnes, G
    Biggerstaff, JP
    Francis, JL
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS105 - PS105